Celastrol and Resveratrol Modulate

cancer stem cells celastrol colon cancer resveratrol sirtuins

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
08 Mar 2022
Historique:
received: 24 01 2022
revised: 24 02 2022
accepted: 06 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 26 3 2022
Statut: epublish

Résumé

Metastatic colorectal cancer (CRC) remains a hard-to-cure neoplasm worldwide. Its curability declines with successive lines of treatment due to the development of various cancer resistance mechanisms and the presence of colorectal cancer stem cells (CSCs). Celastrol and resveratrol are very promising phytochemicals for colon cancer therapy, owing to their pleiotropic activity that enables them to interact with various biological targets. In the present study, the anticancer activities of both compounds were investigated in metastatic colon cancer cells (LoVo cells) and cancer stem-like cells (LoVo/DX). We showed that celastrol is a very potent anti-tumor compound against metastatic colon cancer, capable of attenuating CSC-like cells at the molecular and cellular levels. In contrast, resveratrol has a much greater effect on colon cancer cells that are expressing standard sensitivity to anticancer drugs, than on CSC-like cells. In addition, both polyphenols have different influences on the expression of

Identifiants

pubmed: 35326523
pii: cancers14061372
doi: 10.3390/cancers14061372
pmc: PMC8945991
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Wroclaw Medical University Grant
ID : SUB.D.130.19.040
Organisme : Wroclaw Medical University Grant
ID : ST.D130.16.009

Références

Cancer Lett. 2011 Apr 1;303(1):9-20
pubmed: 21168266
Clin Epigenetics. 2010 Dec 1;1(3-4):101-116
pubmed: 21258631
Chem Biol Interact. 2017 Jun 25;272:72-79
pubmed: 28506552
Oncotarget. 2017 Dec 22;9(70):33403-33415
pubmed: 30279970
J Cell Physiol. 2020 May;235(5):4153-4166
pubmed: 31647128
Life Sci. 2012 Sep 17;91(7-8):279-83
pubmed: 22877649
Curr Res Food Sci. 2020 Nov 24;3:284-295
pubmed: 33305295
Int J Cancer. 2020 Dec 15;147(12):3297-3304
pubmed: 32449165
J Biosci. 2021;46:
pubmed: 33576344
Int J Biol Sci. 2009;5(2):147-52
pubmed: 19173036
Leukemia. 1997 Jul;11(7):1124-30
pubmed: 9205001
Toxicol In Vitro. 2013 Dec;27(8):2127-34
pubmed: 24055891
Semin Cancer Biol. 2016 Oct;40-41:192-208
pubmed: 27609747
World J Clin Cases. 2020 Jun 26;8(12):2425-2437
pubmed: 32607320
Biochem Pharmacol. 2019 Sep;167:107-115
pubmed: 31202733
Stem Cells. 2019 Jan;37(1):42-53
pubmed: 30353615
Cell Death Dis. 2014 Feb 06;5:e1047
pubmed: 24503539
Oncotarget. 2018 Apr 20;9(30):21211-21223
pubmed: 29765532
Ther Adv Med Oncol. 2016 Jan;8(1):57-84
pubmed: 26753006
Cancers (Basel). 2021 Mar 04;13(5):
pubmed: 33806312
Front Oncol. 2020 Sep 08;10:1721
pubmed: 33014852
Front Pharmacol. 2019 Jan 30;10:38
pubmed: 30761005
Cytometry B Clin Cytom. 2004 May;59(1):46-53
pubmed: 15108170
J Transl Sci. 2020 Jun;6(3):
pubmed: 35330670
Biomedicines. 2021 Apr 28;9(5):
pubmed: 33924995
Cancer Lett. 2010 Sep 28;295(2):167-72
pubmed: 20304553
Drug Res (Stuttg). 2022 Jan;72(1):5-17
pubmed: 34412126
Theranostics. 2020 Apr 27;10(13):5845-5864
pubmed: 32483423
Eur J Pharmacol. 2010 Oct 10;644(1-3):32-40
pubmed: 20633549
Oxid Med Cell Longev. 2019 Aug 14;2019:6793957
pubmed: 31485297
Int J Mol Med. 2002 Aug;10(2):193-9
pubmed: 12119558
EMBO Rep. 2020 Apr 3;21(4):e48183
pubmed: 32141187
Mol Cell. 2008 Oct 10;32(1):11-20
pubmed: 18851829
Nutrients. 2016 Mar 05;8(3):145
pubmed: 26959057
Nat Rev Cancer. 2015 Oct;15(10):608-24
pubmed: 26383140
Front Oncol. 2020 Jul 16;10:1038
pubmed: 32766132
Toxicol In Vitro. 2015 Aug;29(5):1156-65
pubmed: 25952326
Front Pharmacol. 2020 Nov 18;11:558741
pubmed: 33364939
Biotechnol Adv. 2018 Nov 1;36(6):1622-1632
pubmed: 29656090
Oncotarget. 2010 Oct;1(6):387-95
pubmed: 21311095
Eur J Pharmacol. 2019 Jan 5;842:146-156
pubmed: 30389635
Biomed Pharmacother. 2018 Oct;106:109-116
pubmed: 29957460
Int J Oncol. 2017 Mar;50(3):787-797
pubmed: 28197625
PLoS One. 2014 Jul 28;9(7):e102535
pubmed: 25068516
J Biol Chem. 2005 Apr 29;280(17):17187-95
pubmed: 15749705

Auteurs

Helena Moreira (H)

Department of Basic Medical Sciences, Faculty of Pharmacy, Wroclaw Medical University, 50-367 Wroclaw, Poland.

Anna Szyjka (A)

Department of Basic Medical Sciences, Faculty of Pharmacy, Wroclaw Medical University, 50-367 Wroclaw, Poland.

Justyna Grzesik (J)

Department of Basic Medical Sciences, Faculty of Pharmacy, Wroclaw Medical University, 50-367 Wroclaw, Poland.

Katarzyna Pelc (K)

Department of Genetic Biochemistry, Faculty of Biotechnology, University of Wroclaw, 50-137 Wroclaw, Poland.

Magdalena Żuk (M)

Department of Genetic Biochemistry, Faculty of Biotechnology, University of Wroclaw, 50-137 Wroclaw, Poland.

Anna Kulma (A)

Department of Genetic Biochemistry, Faculty of Biotechnology, University of Wroclaw, 50-137 Wroclaw, Poland.

Fathi Emhemmed (F)

IPHC, UMR 7178 CNRS, Faculty of Pharmacy, University of Strasbourg, 67081 Illkirch, France.

Christian D Muller (CD)

IPHC, UMR 7178 CNRS, Faculty of Pharmacy, University of Strasbourg, 67081 Illkirch, France.

Kazimierz Gąsiorowski (K)

Department of Basic Medical Sciences, Faculty of Pharmacy, Wroclaw Medical University, 50-367 Wroclaw, Poland.

Ewa Barg (E)

Department of Basic Medical Sciences, Faculty of Pharmacy, Wroclaw Medical University, 50-367 Wroclaw, Poland.

Classifications MeSH